Financial Snapshot

Revenue
$1.235B
TTM
Gross Margin
Net Earnings
-$7.508M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
1016.48%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
$7.494M
Q3 2024
Cash
Q3 2024
P/E
-0.7743
Dec 02, 2024 EST
Free Cash Flow
-$3.067M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017
Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017
Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost Of Revenue
Gross Profit
Gross Profit Margin

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017
Selling, General & Admin $4.212M $5.150M $5.787M $3.960M $5.060M $1.220M $1.240M
YoY Change -18.2% -11.01% 46.13% -21.74% 314.75% -1.61%
% of Gross Profit
Research & Development $3.480M $4.845M $7.529M $2.890M $2.120M $1.020M $590.0K
YoY Change -28.17% -35.66% 160.54% 36.32% 107.84% 72.88%
% of Gross Profit
Depreciation & Amortization $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
% of Gross Profit
Operating Expenses $7.692M $11.07M $14.10M $7.300M $7.720M $2.500M $1.870M
YoY Change -30.48% -21.53% 93.17% -5.44% 208.8% 33.69%
Operating Profit -$7.692M -$11.07M -$14.10M
YoY Change -30.48% -21.53%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017
Interest Expense -$153.2K -$757.5K $0.00 $0.00 $0.00 -$140.0K
YoY Change -79.78% -100.0%
% of Operating Profit
Other Income/Expense, Net $0.00 -$306.4K -$212.3K $100.0K $10.00K
YoY Change -100.0% 44.34% -312.27% 900.0%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017
Pretax Income -$7.845M -$11.37M -$14.31M -$7.200M -$7.700M -$2.500M -$2.020M
YoY Change -31.01% -20.55% 98.8% -6.49% 208.0% 23.76%
Income Tax
% Of Pretax Income
Net Earnings -$7.845M -$11.37M -$14.31M -$7.200M -$7.700M -$2.500M -$2.020M
YoY Change -31.01% -20.55% 98.8% -6.49% 208.0% 23.76%
Net Earnings / Revenue
Basic Earnings Per Share -$2.30 -$9.50 -$16.02
Diluted Earnings Per Share -$2.30 -$8.79 -$641.0K -$582.5K -$840.6K -$497.0K -$214.4K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017
Cash & Short-Term Investments $9.292M $6.638M $10.43M $4.690M $2.490M $280.0K $1.230M
YoY Change 39.99% -36.36% 122.41% 88.35% 789.29% -77.24%
Cash & Equivalents
Short-Term Investments $0.00 $209.3K $1.893M $2.060M $800.0K
Other Short-Term Assets $135.4K $88.45K $93.97K $90.00K $140.0K $220.0K $0.00
YoY Change 53.04% -5.87% 4.41% -35.71% -36.36%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $9.428M $6.726M $10.58M $4.780M $2.640M $500.0K $1.230M
YoY Change 40.16% -36.39% 121.24% 81.06% 428.0% -59.35%
Property, Plant & Equipment $55.17K $0.00 $0.00 $0.00 $0.00
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $37.40K $33.00K $410.0K $410.0K
YoY Change 13.33% -91.95% 0.0%
Other Assets $0.00 $200.0K
YoY Change -100.0%
Total Long-Term Assets $92.57K $33.00K $410.0K $460.0K $200.0K $0.00 $0.00
YoY Change 180.52% -91.95% -10.87% 130.0%
Total Assets $9.520M $6.759M $10.99M $5.240M $2.840M $500.0K $1.230M
YoY Change
Accounts Payable $35.59K $695.0K $361.0K $130.0K $400.0K $140.0K $50.00K
YoY Change -94.88% 92.54% 177.66% -67.5% 185.71% 180.0%
Accrued Expenses $643.1K $692.7K $506.8K $180.0K $40.00K $210.0K $0.00
YoY Change -7.17% 36.68% 181.57% 350.0% -80.95%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $678.7K $1.388M $867.8K $310.0K $440.0K $350.0K $50.00K
YoY Change -51.1% 59.92% 179.93% -29.55% 25.71% 600.0%
Long-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $26.33K $250.0K $235.0K $290.0K
YoY Change -89.47% 6.38% -18.97%
Total Long-Term Liabilities $26.33K $250.0K $235.0K $290.0K $0.00 $0.00 $0.00
YoY Change -89.47% 6.38% -18.97%
Total Liabilities $705.0K $1.638M $1.103M $600.0K $440.0K $350.0K $50.00K
YoY Change -56.95% 48.51% 83.8% 36.36% 25.71% 600.0%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017
Basic Shares Outstanding 3.409M shares 1.198M shares 893.2K shares
Diluted Shares Outstanding 3.409M shares 1.198M shares 893.2K shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $5.813 Million

About Hoth Therapeutics, Inc.

Hoth Therapeutics, Inc. engages in the development of new generation therapies for dermatological disorders. The company is headquartered in New York City, New York and currently employs 2 full-time employees. The company went IPO on 2019-02-15. The firm is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); a treatment for traumatic brain injury and ischemic stroke (HT-TBI) and a treatment and/or prevention for Alzheimer’s or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004), and a treatment for acne as well as inflammatory bowel diseases (HT-003). Its development products include HT-001, HT-KIT, HT-ALZ, and HT-TBI. Its BioLexa Platform is a proprietary, patented, drug compound platform for the treatment of eczema. The firm also has interests in certain other assets being developed by third parties including a treatment for patients with lupus.

Industry: Pharmaceutical Preparations Peers: AGILE THERAPEUTICS INC AYTU BIOPHARMA, INC Barrel Energy Inc. Cingulate Inc. Jaguar Health, Inc. JOHNSON & JOHNSON Pulmatrix, Inc. Unrivaled Brands, Inc. WEED, INC. Virpax Pharmaceuticals, Inc.